Abstract | BACKGROUND:: CASE PRESENTATION:: A patient was found to have a locally advanced serous carcinoma, causing secondary bowel obstruction. Furthermore, due to compromised oral access, the patient's oral antiparkinsonian medications for motor control were converted to transdermal rotigotine. Unfortunately, the patient's nausea and vomiting was refractory to a number of recommended antiemetic options. CASE MANAGEMENT:: CASE OUTCOME:: CONCLUSIONS::
|
Authors | Jonathan Hindmarsh, Sharlene Hindmarsh, Mark Lee, Richard Telford |
Journal | Palliative medicine
(Palliat Med)
Vol. 33
Issue 1
Pg. 109-113
(Jan 2019)
ISSN: 1477-030X [Electronic] England |
PMID | 30404581
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antiparkinson Agents
- Antipsychotic Agents
- Dopamine Agonists
- Tetrahydronaphthalenes
- Thiophenes
- rotigotine
- Methotrimeprazine
|
Topics |
- Administration, Cutaneous
- Aged
- Antiparkinson Agents
(administration & dosage, therapeutic use)
- Antipsychotic Agents
(administration & dosage, therapeutic use)
- Dopamine Agonists
(administration & dosage, therapeutic use)
- Female
- Humans
- Methotrimeprazine
(administration & dosage, therapeutic use)
- Nausea
(drug therapy, etiology)
- Parkinson Disease
(complications)
- Tetrahydronaphthalenes
(administration & dosage, therapeutic use)
- Thiophenes
(administration & dosage, therapeutic use)
- Transdermal Patch
- Treatment Outcome
- Vomiting
(drug therapy, etiology)
|